Drugs / BacoMind®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04927338 | Dec 2022 → Apr 2026 overdue | persian gulf syndrome | Nova Southeastern University | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BacoMind | “BacoMind® (Bacopa monnieri standardized extract)” NCT04927338 ↗ |